Litcius/Paper detail

lncRNA DUXAP8 Facilitates Multiple Malignant Phenotypes and Resistance to PARP Inhibitor in HCC via Upregulating FOXM1

Yu Hu, Xian Zhang, Hongyan Zai, Wei Jiang, Xiao Liang, Qin Zhu

2020Molecular Therapy — Oncolytics53 citationsDOIOpen Access PDF

Abstract

. Mechanistically, DUXAP8 upregulated FOXM1 expression by sponging miR-485-5p and interacting with the RNA-binding protein Fused in Sarcoma (FUS). Functionally, FOXM1 essentially mediated the oncogenic phenotypes of DUXAP8. Collectively, DUXAP8 acts through two distinct mechanisms to upregulate FOXM1 and becomes a pleotropic oncogenic lncRNA in HCC.

Topics & Concepts

BiologyFOXM1Long non-coding RNACancer researchDownregulation and upregulationMetastasisRNAMolecular biologyGeneCancerGeneticsCancer-related molecular mechanisms researchFOXO transcription factor regulationRNA modifications and cancer
lncRNA DUXAP8 Facilitates Multiple Malignant Phenotypes and Resistance to PARP Inhibitor in HCC via Upregulating FOXM1 | Litcius